4P FDG PET derived metabolic tumor volume (MTV) and its transcriptomic correlates as biomarker to predict efficacy of immune checkpoint inhibitors (ICB) alone or in combination with chemotherapy in advanced NSCLC: A multicentric study. (December 2022) - Dall'Olio, F.G.; Garcia, C.A.; Zrafi, W.S.; Fortunati, E.; Bettayeb, A.; Zalcman, G.; Remon Masip, J.; Hendriks, L.; Tagliamento, M.; Bonardel, G.; Helissey, C.; Roelants, V.; et al.